Published in
Elsevier, Journal of Allergy and Clinical Immunology, 6(142), p. 1983-1987, 2018
DOI: 10.1016/j.jaci.2018.07.030
Links
Tools
Genetically engineered cell factories produce glycoengineered vaccines that target antigen presenting cells and reduce antigen specific T-cell reactivity
Journal article published in 2018 by
Caroline B. K. Mathiesen,
Michael C. Carlsson,
Stephanie Brand,
Svenning Rune Möller,
Manja Idorn 
,
Per thor Straten,
Per T. Straten,
Anders E. Pedersen,
Sally Dabelsteen ,
Adnan Halim ,
Peter Adler Würtzen,
Jens Brimnes,
Henrik Ipsen,
Bent L. Petersen,
Hans H. Wandall
,
Per thor Straten,
Per T. Straten,
Anders E. Pedersen,
Sally Dabelsteen ,
Adnan Halim ,
Peter Adler Würtzen,
Jens Brimnes,
Henrik Ipsen,
Bent L. Petersen,
Hans H. Wandall
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 